These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 8621768
21. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression. Abbud RA, Kelleher R, Melmed S. Endocrinology; 2004 Feb; 145(2):867-80. PubMed ID: 14576184 [Abstract] [Full Text] [Related]
22. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis. Auernhammer CJ, Chesnokova V, Melmed S. Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823 [Abstract] [Full Text] [Related]
23. Leukemia inhibitory factor as an intrapituitary mediator of ACTH secretion. Schwartz J, Ray DW, Perez FM. Neuroendocrinology; 1999 Jan; 69(1):34-43. PubMed ID: 9892849 [Abstract] [Full Text] [Related]
24. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R. J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310 [Abstract] [Full Text] [Related]
31. Leukemia inhibitory factor signaling is implicated in embrionic development of the HPA axis. Ware CB, Kariagina A, Zonis S, Alon D, Chesnokova V. FEBS Lett; 2005 Aug 15; 579(20):4465-9. PubMed ID: 16081071 [Abstract] [Full Text] [Related]
32. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies. Murakami-Mori K, Taga T, Kishimoto T, Nakamura S. J Clin Invest; 1995 Sep 15; 96(3):1319-27. PubMed ID: 7657807 [Abstract] [Full Text] [Related]
33. Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein. Jin WD, Boutillier AL, Glucksman MJ, Salton SR, Loeffler JP, Roberts JL. Mol Endocrinol; 1994 Oct 15; 8(10):1377-88. PubMed ID: 7854355 [Abstract] [Full Text] [Related]
37. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA. Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P. FEBS Lett; 2000 Jul 28; 478(1-2):100-4. PubMed ID: 10922477 [Abstract] [Full Text] [Related]
38. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation. Chesnokova V, Kariagina A, Melmed S. Am J Physiol Endocrinol Metab; 2002 May 28; 282(5):E1110-8. PubMed ID: 11934677 [Abstract] [Full Text] [Related]
39. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M. Vernallis AB, Hudson KR, Heath JK. J Biol Chem; 1997 Oct 24; 272(43):26947-52. PubMed ID: 9341130 [Abstract] [Full Text] [Related]
40. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Wang Z, Ren SG, Melmed S. Endocrinology; 1996 Jul 24; 137(7):2947-53. PubMed ID: 8770918 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]